Horacio Mingrone

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Pedro Cahn, Anton Pozniak, Horacio Mingrone et al. · The Lancet · 2013 · 514 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +16

Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection

David A. Cooper, Jayvant Heera, James Goodrich et al. · The Journal of Infectious Diseases · 2010 · 265 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters

M. Eugenia Socías, Omar Sued, Natalia Laufer et al. · Journal of the International AIDS Society · 2011 · 56 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1–Infected Subjects at 48 Weeks

Roberto Zajdenverg, Thomas Podsadecki, Sharlaa Badal‐Faesen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia

Carlos R. Salvarezza, Horacio Mingrone, H. Fachinelli et al. · Journal of Antimicrobial Chemotherapy · 1998 · 21 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17